Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel therapeutics for fibroproliferative diseases reported by Scios

Aug. 16, 2005

Clinical data confirm the efficacy of solifenacin in overactive bladder

Aug. 16, 2005

TH-070 begins phase III study for BPH

Aug. 10, 2005

Interim safety results of pivotal study of NX-1207 for BPH

Aug. 10, 2005

Phase IIb studies begin for PT-141 for erectile dysfunction

Aug. 9, 2005

Kyorin and LG Life Sciences sign memorandum of understanding for KRP-197

Aug. 4, 2005

Sevelamer decreases mortality and morbidity of hemodialysis patients

Aug. 3, 2005

New class of intestinal Pi absorption inhibitor

July 28, 2005

Updated labeling for Cialis, Levitra and Viagra

July 20, 2005

Therapeutic benefits of melatonin in hemodialysis patients

July 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...